Breaking News Instant updates and real-time market news.

HLTRF

HLS Therapeutics

$0.00 /

+ (+0.00%)

09:08
10/01/20
10/01
09:08
10/01/20
09:08

HLS Therapeutics price target raised to C$33.25 from C$31 at Clarus

Clarus analyst Noel Atkinson raised the firm's price target on HLS Therapeutics to C$33.25 from C$31 and keeps a Buy rating on the shares after the company acquired the rights to royalty interests on global sales of four different products

HLTRF HLS Therapeutics
$0.00 /

+ (+0.00%)

07/21/20 Stifel
HLS Therapeutics price target raised to C$36 from C$35 at Stifel

TODAY'S FREE FLY STORIES

Earnings
Sprouts Farmers Market sees FY20 adj. EPS $2.26-$2.30, consensus $2.13 » 16:06
10/28/20
10/28
16:06
10/28/20
16:06
SFM

Sprouts Farmers Market

$20.38 /

-0.03 (-0.15%)

"We remain confident…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFM Sprouts Farmers Market
$20.38 /

-0.03 (-0.15%)

SFM Sprouts Farmers Market
$20.38 /

-0.03 (-0.15%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 Gordon Haskett
Sprouts Farmers Market downgraded to Hold from Buy at Gordon Haskett
08/06/20 Credit Suisse
Sprouts Farmers Market assumed with a Neutral at Credit Suisse
07/30/20
Fly Intel: Top five analyst initiations
SFM Sprouts Farmers Market
$20.38 /

-0.03 (-0.15%)

SFM Sprouts Farmers Market
$20.38 /

-0.03 (-0.15%)

SFM Sprouts Farmers Market
$20.38 /

-0.03 (-0.15%)

SFM Sprouts Farmers Market
$20.38 /

-0.03 (-0.15%)

Earnings
Cognizant raises FY20 adjusted EPS view to $3.63-$3.67 from $3.48-$3.58 » 16:05
10/28/20
10/28
16:05
10/28/20
16:05
CTSH

Cognizant

$71.21 /

-2.16 (-2.94%)

Consensus for FY20 EPS is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$71.21 /

-2.16 (-2.94%)

CTSH Cognizant
$71.21 /

-2.16 (-2.94%)

10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 BofA
Cognizant upgraded to Buy from Neutral at BofA
CTSH Cognizant
$71.21 /

-2.16 (-2.94%)

CTSH Cognizant
$71.21 /

-2.16 (-2.94%)

CTSH Cognizant
$71.21 /

-2.16 (-2.94%)

CTSH Cognizant
$71.21 /

-2.16 (-2.94%)

Earnings
Cree sees Q2 adjusted EPS (27c)-(23c), consensus (18c) » 16:05
10/28/20
10/28
16:05
10/28/20
16:05
CREE

Cree

$66.29 /

-1.7 (-2.50%)

Sees Q2 revenue from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$66.29 /

-1.7 (-2.50%)

CREE Cree
$66.29 /

-1.7 (-2.50%)

10/20/20 Piper Sandler
Cree price target raised to $73 from $65 at Piper Sandler
09/22/20 Morgan Stanley
Morgan Stanley says Cree poised to benefit from investments in EV, clean energy
09/04/20 Canaccord
Cree design wins add $1B market opportunity, says Canaccord
08/20/20 Citi
Cree price target lowered to $71 from $82 at Citi
CREE Cree
$66.29 /

-1.7 (-2.50%)

CREE Cree
$66.29 /

-1.7 (-2.50%)

CREE Cree
$66.29 /

-1.7 (-2.50%)

CREE Cree
$66.29 /

-1.7 (-2.50%)

Hot Stocks
FormFactor announces $50M share repurchase program » 16:05
10/28/20
10/28
16:05
10/28/20
16:05
FORM

FormFactor

$28.03 /

-1.13 (-3.88%)

The Company's Board…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FORM FormFactor
$28.03 /

-1.13 (-3.88%)

FORM FormFactor
$28.03 /

-1.13 (-3.88%)

09/09/20
Fly Intel: Top five analyst upgrades
09/09/20 Craig-Hallum
FormFactor upgraded to Buy at Craig-Hallum
09/09/20 Craig-Hallum
FormFactor upgraded to Buy from Hold at Craig-Hallum
08/17/20 Needham
FormFactor upgraded to Buy from Hold at Needham
FORM FormFactor
$28.03 /

-1.13 (-3.88%)

FORM FormFactor
$28.03 /

-1.13 (-3.88%)

Earnings
Sprouts Farmers Market sees Q4 adj. EPS 36c-40c, consensus 38c » 16:05
10/28/20
10/28
16:05
10/28/20
16:05
SFM

Sprouts Farmers Market

$20.41 /

+ (+0.00%)

As customers continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFM Sprouts Farmers Market
$20.41 /

+ (+0.00%)

SFM Sprouts Farmers Market
$20.41 /

+ (+0.00%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 Gordon Haskett
Sprouts Farmers Market downgraded to Hold from Buy at Gordon Haskett
08/06/20 Credit Suisse
Sprouts Farmers Market assumed with a Neutral at Credit Suisse
07/30/20
Fly Intel: Top five analyst initiations
SFM Sprouts Farmers Market
$20.41 /

+ (+0.00%)

SFM Sprouts Farmers Market
$20.41 /

+ (+0.00%)

SFM Sprouts Farmers Market
$20.41 /

+ (+0.00%)

SFM Sprouts Farmers Market
$20.41 /

+ (+0.00%)

Earnings
Visa reports Q4 EPS $1.12, consensus $1.10 » 16:05
10/28/20
10/28
16:05
10/28/20
16:05
V

Visa

$181.07 /

-8.93 (-4.70%)

Reports Q4 revenue $5.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
V Visa
$181.07 /

-8.93 (-4.70%)

V Visa
$181.07 /

-8.93 (-4.70%)

10/21/20 Barclays
Visa price target raised to $235 from $225 at Barclays
10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
10/02/20 Jefferies
Visa price target raised to $205 from $185 at Jefferies
09/21/20 KeyBanc
Visa price target raised to $230 from $215 at KeyBanc
V Visa
$181.07 /

-8.93 (-4.70%)

  • 13
    Oct
V Visa
$181.07 /

-8.93 (-4.70%)

V Visa
$181.07 /

-8.93 (-4.70%)

V Visa
$181.07 /

-8.93 (-4.70%)

Earnings
Cree reports Q1 adjusted EPS (19c), consensus (21c) » 16:04
10/28/20
10/28
16:04
10/28/20
16:04
CREE

Cree

$66.38 /

-1.61 (-2.37%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$66.38 /

-1.61 (-2.37%)

CREE Cree
$66.38 /

-1.61 (-2.37%)

10/20/20 Piper Sandler
Cree price target raised to $73 from $65 at Piper Sandler
09/22/20 Morgan Stanley
Morgan Stanley says Cree poised to benefit from investments in EV, clean energy
09/04/20 Canaccord
Cree design wins add $1B market opportunity, says Canaccord
08/20/20 Citi
Cree price target lowered to $71 from $82 at Citi
CREE Cree
$66.38 /

-1.61 (-2.37%)

CREE Cree
$66.38 /

-1.61 (-2.37%)

CREE Cree
$66.38 /

-1.61 (-2.37%)

CREE Cree
$66.38 /

-1.61 (-2.37%)

Earnings
Pinterest sees Q4 revenue up 60 from last year » 16:04
10/28/20
10/28
16:04
10/28/20
16:04
PINS

Pinterest

$49.20 /

-3.38 (-6.43%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$49.20 /

-3.38 (-6.43%)

PINS Pinterest
$49.20 /

-3.38 (-6.43%)

10/26/20 JPMorgan
Pinterest price target raised to $57 from $37 at JPMorgan
10/26/20 KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
PINS Pinterest
$49.20 /

-3.38 (-6.43%)

PINS Pinterest
$49.20 /

-3.38 (-6.43%)

PINS Pinterest
$49.20 /

-3.38 (-6.43%)

PINS Pinterest
$49.20 /

-3.38 (-6.43%)

Earnings
FormFactor reports Q3 EPS 39c, consensus 35c » 16:04
10/28/20
10/28
16:04
10/28/20
16:04
FORM

FormFactor

$28.04 /

-1.12 (-3.84%)

Reports Q3 revenue $178M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FORM FormFactor
$28.04 /

-1.12 (-3.84%)

FORM FormFactor
$28.04 /

-1.12 (-3.84%)

09/09/20
Fly Intel: Top five analyst upgrades
09/09/20 Craig-Hallum
FormFactor upgraded to Buy at Craig-Hallum
09/09/20 Craig-Hallum
FormFactor upgraded to Buy from Hold at Craig-Hallum
08/17/20 Needham
FormFactor upgraded to Buy from Hold at Needham
FORM FormFactor
$28.04 /

-1.12 (-3.84%)

FORM FormFactor
$28.04 /

-1.12 (-3.84%)

Hot Stocks
Pinterest reports Q3 global MAUs up 37% to 442M » 16:04
10/28/20
10/28
16:04
10/28/20
16:04
PINS

Pinterest

$49.17 /

-3.41 (-6.49%)

Reports Q3 adj. EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

10/26/20 JPMorgan
Pinterest price target raised to $57 from $37 at JPMorgan
10/26/20 KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

PINS Pinterest
$49.17 /

-3.41 (-6.49%)

Earnings
Sprouts Farmers Market reports Q3 adj. EPS 52c, consensus 36c » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
SFM

Sprouts Farmers Market

$20.37 /

-0.04 (-0.20%)

Reports Q3 revenue $1.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 Gordon Haskett
Sprouts Farmers Market downgraded to Hold from Buy at Gordon Haskett
08/06/20 Credit Suisse
Sprouts Farmers Market assumed with a Neutral at Credit Suisse
07/30/20
Fly Intel: Top five analyst initiations
SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

SFM Sprouts Farmers Market
$20.37 /

-0.04 (-0.20%)

Earnings
Gilead sees core business gradually recovering in Q4 and into 1H21 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
GILD

Gilead

$58.96 /

-1.065 (-1.77%)

The COVID-19 pandemic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

GILD Gilead
$58.96 /

-1.065 (-1.77%)

Hot Stocks
Amgen sees FY20 share repurchases at lower end of $3B-$5B range  16:03
10/28/20
10/28
16:03
10/28/20
16:03
AMGN

Amgen

$217.70 /

-5.69 (-2.55%)

 
ShowHide Related Items >><<
AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

AMGN Amgen
$217.70 /

-5.69 (-2.55%)

Earnings
Pinterest reports Q3 EPS 13c, consensus 2c » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
PINS

Pinterest

$49.13 /

-3.45 (-6.56%)

Reports Q3 revenue $443M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

10/26/20 JPMorgan
Pinterest price target raised to $57 from $37 at JPMorgan
10/26/20 KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

PINS Pinterest
$49.13 /

-3.45 (-6.56%)

Earnings
Gilead narrows FY20 adjusted EPS view to $6.25-$6.60 from $6.25-$7.65 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
GILD

Gilead

$58.95 /

-1.07 (-1.78%)

Consensus $6.98. Narrows…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

Earnings
Amgen raises FY20 adjusted EPS view to $15.80-$16.15 from $15.10-$15.75 » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
AMGN

Amgen

$217.45 /

-5.94 (-2.66%)

FY20 consensus $15.77.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

AMGN Amgen
$217.45 /

-5.94 (-2.66%)

Earnings
Cognizant reports Q3 adjusted EPS 97c, consensus 90c » 16:03
10/28/20
10/28
16:03
10/28/20
16:03
CTSH

Cognizant

$71.40 /

-1.97 (-2.69%)

Reports Q3 revenue $4.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 BofA
Cognizant upgraded to Buy from Neutral at BofA
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

Earnings
Cognizant reports Q3 adjusted EPS 97c, consensus 90c » 16:02
10/28/20
10/28
16:02
10/28/20
16:02
CTSH

Cognizant

$71.40 /

-1.97 (-2.69%)

Reports Q3 revenue $4.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
10/13/20 Susquehanna
Cognizant upgraded to Positive from Neutral at Susquehanna
09/11/20
Fly Intel: Top five analyst upgrades
09/11/20 BofA
Cognizant upgraded to Buy from Neutral at BofA
CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

CTSH Cognizant
$71.40 /

-1.97 (-2.69%)

Earnings
Gilead Sciences reports Q3 adjusted EPS $2.11, consensus $1.95 » 16:02
10/28/20
10/28
16:02
10/28/20
16:02
GILD

Gilead

$58.95 /

-1.07 (-1.78%)

Reports Q3 revenue $6.6B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

06:28 Today UBS
Gilead initiated with a Neutral at UBS
10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

GILD Gilead
$58.95 /

-1.07 (-1.78%)

Earnings
NIC Inc. expects to be above high end of prior 2020 guidance » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
EGOV

NIC Inc.

$21.07 /

+0.06 (+0.29%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGOV NIC Inc.
$21.07 /

+0.06 (+0.29%)

12:31 Today DA Davidson
NIC Inc. upgraded to Buy on increased confidence in outlook at DA Davidson
12:26 Today DA Davidson
NIC Inc. upgraded to Buy from Neutral at DA Davidson
04/27/20 Barrington
NIC Inc. price target raised to $30 from $26 at Barrington
04/09/20 DA Davidson
NIC Inc. downgraded to Neutral from Buy at DA Davidson
EGOV NIC Inc.
$21.07 /

+0.06 (+0.29%)

EGOV NIC Inc.
$21.07 /

+0.06 (+0.29%)

Earnings
Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
AMGN

Amgen

$217.77 /

-5.62 (-2.52%)

Reports Q3 revenue $6.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

Earnings
Amgen reports Q3 adjusted EPS $4.37, consensus $3.80 » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
AMGN

Amgen

$217.77 /

-5.62 (-2.52%)

Reports Q3 revenue $6.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

06:22 Today UBS
Amgen initiated with a Neutral at UBS
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/26/20 Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

AMGN Amgen
$217.77 /

-5.62 (-2.52%)

Earnings
Central Valley Community reports Q3 EPS 35c, consensus 33c » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
CVCY

Central Valley Community

$13.06 /

-0.62 (-4.53%)

"Our financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVCY Central Valley Community
$13.06 /

-0.62 (-4.53%)

CVCY Central Valley Community
$13.06 /

-0.62 (-4.53%)

10/13/20 Piper Sandler
Central Valley Community price target lowered to $15 from $17 at Piper Sandler
09/08/20 Janney Montgomery Scott
Janney Montgomery Scott upgrades Central Valley Community to Buy after selloff
09/08/20 Janney Montgomery Scott
Central Valley Community upgraded to Buy from Neutral at Janney Montgomery Scott
04/16/20
DA Davidson upgrades Central Valley Community to Buy on resilient NIM
CVCY Central Valley Community
$13.06 /

-0.62 (-4.53%)

Downgrade
Concho Resources downgraded to Sector Perform from Outperform at Scotiabank » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
CXO

Concho Resources

$41.58 /

-2.1 (-4.81%)

Scotiabank analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

10/23/20 Stephens
Concho Resources cut to Equal Weight after ConocoPhillips deal at Stephens
10/23/20 Stephens
Concho Resources downgraded to Equal Weight from Overweight at Stephens
10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
10/21/20 US Capital Advisors
Concho Resources downgraded to Hold from Buy at US Capital Advisors
CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

CXO Concho Resources
$41.58 /

-2.1 (-4.81%)

Earnings
NIC Inc. reports Q3 EPS 37c, consensus 21c » 16:01
10/28/20
10/28
16:01
10/28/20
16:01
EGOV

NIC Inc.

$21.09 /

+0.08 (+0.38%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGOV NIC Inc.
$21.09 /

+0.08 (+0.38%)

12:31 Today DA Davidson
NIC Inc. upgraded to Buy on increased confidence in outlook at DA Davidson
12:26 Today DA Davidson
NIC Inc. upgraded to Buy from Neutral at DA Davidson
04/27/20 Barrington
NIC Inc. price target raised to $30 from $26 at Barrington
04/09/20 DA Davidson
NIC Inc. downgraded to Neutral from Buy at DA Davidson
EGOV NIC Inc.
$21.09 /

+0.08 (+0.38%)

EGOV NIC Inc.
$21.09 /

+0.08 (+0.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.